1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with ascorbic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marquardt, H; Wölfle, D | 1 |
| Chayama, K; Goto, C; Hara, K; Higashi, Y; Jitsuiki, D; Kimura, M; Nakagawa, K; Nishioka, K; Noma, K; Oshima, T; Umemura, T; Yoshizumi, M | 1 |
2 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and ascorbic acid
| Article | Year |
|---|---|
Antioxidants inhibit the enhancement of malignant cell transformation induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Anticarcinogenic Agents; Antioxidants; Ascorbic Acid; Carcinogens; Cell Transformation, Neoplastic; Drug Interactions; Enzyme Inhibitors; Fibroblasts; Isoquinolines; Mannitol; Methylnitronitrosoguanidine; Mice; Mice, Inbred C3H; Piperazines; Polychlorinated Dibenzodioxins; Protein Kinase C; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Vitamin E | 1996 |
Smoking, endothelial function, and Rho-kinase in humans.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetylcholine; Adult; Antioxidants; Ascorbic Acid; Endothelium, Vascular; Enzyme Inhibitors; Forearm; Humans; Intracellular Signaling Peptides and Proteins; Male; Muscle, Smooth, Vascular; Nitroprusside; omega-N-Methylarginine; Plethysmography; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Regional Blood Flow; rho-Associated Kinases; Smoking; Vasodilator Agents | 2005 |